Intrapleural r-tPA in association with low-molecular heparin may cause massive hemothorax resulting in hypovolemia

Respiration. 2011;81(6):513-6. doi: 10.1159/000321249. Epub 2010 Nov 9.

Abstract

The use of intrapleural instillation of recombinant tissue plasminogen activator (r-tPA) in the treatment of pleural infection may increase pleural fluid drainage associated with a clinical and imaging improvement, leading to a faster resolution. The use of r-tPA is generally well tolerated. Here we report 2 cases of massive pleural hemorrhage resulting in life-threatening hypovolemia, in 2 patients treated with intrapleural r-tPA for a pleural infection, who were simultaneously receiving systemic anticoagulation (1 therapeutic, the second prophylactic) with low-molecular weight heparin. It appears that the decision of treating pleural infection with r-tPA in patients receiving therapeutic or prophylactic systemic anticoagulation must be well balanced and in case of association of these compounds, close monitoring is necessary.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Drug Therapy, Combination / adverse effects
  • Fibrinolytic Agents / adverse effects*
  • Hemothorax / chemically induced*
  • Hemothorax / complications
  • Heparin, Low-Molecular-Weight / adverse effects*
  • Humans
  • Hypovolemia / etiology*
  • Male
  • Middle Aged
  • Pleural Effusion / drug therapy
  • Tissue Plasminogen Activator / adverse effects*

Substances

  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight
  • Tissue Plasminogen Activator